![]() |
Ocrelizumab
|
Yet another miracle drug being rolled out. Maybe this one will be better than the others!
|
Ocrelizumab is a humanised monoclonal antibody which blocks the action of a protein called CD20, found on mature B cells. Because of this it is immunosuppressive.
Phase 3 clinical trials of it in the context of MS look very encouraging. It is currently under consideration by the FDA for regulatory approval. There is more about this here; https://www.mssociety.org.uk/ms-rese...ne/ocrelizumab. |
Actually hasn't it been fast-tracked for speedier FDA approval?
|
Yes, it is on the "Breakthrough Therapy Designation" list.
|
Hearing good things about this stuff. I hope they find it works for SPMS also.
Wouldn't that be nice? |
Today read another promising thing about this, will also ask MS neurosuheon on May 13 John Hopkins doctor, for what that's worth.
|
As always, holding my breath, hoping.
|
Made it into the Ocrelizumab study
Quote:
|
1week in.....
I got a little light headed in the middle when I got up real fast (real fast is a relative term for me). But it was gone before the treatment was over. I didn't experience even the mild side effects. This alone was a blessing over the "flu like" side effects multiple times a week with Rebif. Next week I get the second half of the first dose. My fingers remain crossed.
|
All times are GMT -5. The time now is 09:15 AM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.